Skip to content
Friday, February 3, 2023
HealthCare Middle East & Africa Magazine

No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa

  • HOME
  • TOPICS
    • MERGERS, INVESTMENTS & FUNDING
    • DISEASES UPDATES
    • HOSPITALS
    • PHARMACEUTICALS
    • PEOPLE NEWS
    • GOVERNMENT
  • THE MAGAZINE
    • About HealthCare Middle East & Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • COMPANY PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • Siemens Healthineers snaps multi-year pact with Unilabs worth over US$219M
  • <strong>India’s Ministry of Finance sets aside US$10B for the health sector in the 2023/24 budget</strong>
  • Ministry of Health concerned with rising malaria cases in the past year
  • eHealth Africa upgrades its application to improve public health outcomes
  • NHA appoints Praveen Sharma as Director, RS Sharma tenure ends as CEO
  • Action needed on trafficked medical products - United Nations Office on Drugs and Crime
  • African leaders commit to end AIDS among children by 2030
  • <strong>President of Ghana launches 300-bed capacity block at 37 Military Hospital</strong>
  • Apollo Indraprastha Hospitals co-hosts meeting with MediSage on cancer management
  • <strong>MoHAP, DoH and DHA announce</strong> <strong>seamless health data integration in the UAE</strong>
You are here
  • Home
  • US FDA

Tag: US FDA

Dr. Reddy’s blockbuster drug Difluprednate Ophthalmic Emulsion enters the U.S. market

31 January 20231 February 2023

INDIA – Dr. Reddy’s Laboratories has secured the U.S. Food and Drug Administration (USFDA) approval for its eye drops for post-surgery care, Difluprednate Ophthalmic Emulsion 0.05%. Following the regulatory approval,…

Read More

FDA approves Merck’s Keytruda as adjuvant cancer treatment regardless of tumor’s PD-L1 expression levels

30 January 202330 January 2023

USA — The U.S. Food and Drug Administration (FDA) has cleared Merck & Co.’s immunotherapy Keytruda to treat early cases of lung cancer despite mixed results in the main study…

Read More

FDA revokes authorization for AstraZeneca’s Covid antibody drug Evusheld citing ineffectiveness

29 January 202330 January 2023

USA — Evusheld, a preventative monoclonal antibody treatment for COVID-19, has lost its emergency use authorization in the United States because it is unlikely to be effective against the coronavirus…

Read More

FDA approves Eli Lilly’s drug for advanced mantle cell lymphoma, to retail at US$21,000 per month

29 January 202330 January 2023

USA — The US Food and Drug Administration (FDA) has approved Eli Lilly and Co.’s drug (pirtobrutinib) for the treatment of a rare form of blood cancer. The indication aims…

Read More

U.S., Switzerland sign pharmaceutical good manufacturing practices agreement

26 January 202326 January 2023

USA — The U.S. FDA has signed an agreement with Switzerland that will allow each country to rely on the “other’s good manufacturing practice inspections of pharmaceutical manufacturing facilities, avoiding…

Read More

Sun Pharma unveils its novel injection for neonatal seizures in the US

25 January 202325 January 2023

INDIA – Sun Pharma has launched its phenobarbital sodium injection for the treatment of neonatal seizures, SEZABY, in the United States (US). The Mumbai-based multinational pharmaceutical company has expanded its…

Read More

FDA details approach for finding optimal dosages for new cancer drugs

18 January 202319 January 2023

USA — The US Food and Drug Administration (FDA) has issued a draft guidance to help sponsors identify the optimal dosage for cancer drugs in clinical development and in it,…

Read More

Sun Pharma introduces novel anti-cancer drug, FDA issues warning letter to its Halol plant

16 January 202316 January 2023

INDIA – Sun Pharmaceutical Industries Limited (Sun Pharma) has expanded its product portfolio with the launch of its novel anti-cancer drug Palbociclib under brand name ” PALENOTM ” in India.…

Read More

FDA approves Novo Nordisk’s diabetes pill as first-line therapy

16 January 202316 January 2023

USA — The US Food and Drug Administration (FDA) has approved a label update for Novo Nordisk’s oral semaglutide (Rybelsus) allowing the agent to be used as an initial treatment…

Read More

Dr. Reddy’s nabs trademark rights of high-quality breast cancer drug from Pfizer

16 January 202319 January 2023

INDIA – Dr. Reddy’s Laboratories Ltd. has acquired the domestic sale rights for breast cancer drug PRIMCYV® from Pfizer Products India Pvt Ltd. The trademark rights acquisition will build on…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

Africa Health Expo 300x600 Sidebar

LATEST NEWS

  • Siemens Healthineers snaps multi-year pact with Unilabs worth over US$219M
  • India’s Ministry of Finance sets aside US$10B for the health sector in the 2023/24 budget
  • Ministry of Health concerned with rising malaria cases in the past year
  • eHealth Africa upgrades its application to improve public health outcomes
  • NHA appoints Praveen Sharma as Director, RS Sharma tenure ends as CEO

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Cancer Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS Hospitals India Japan Johnson & Johnson Kenya Malaria Merck Mergers, Investments & Funding Moderna MOH Kenya Nigeria Novartis Partnerships Pfizer Pharmaceuticals Public Health Roche Rwanda Sanofi Science & Technology South Africa Switzerland Tanzania Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

HealthCare Middle East & Africa Follow

Africa's No. 1 magazine that showcases the people, businesses and market trends in the pharmaceuticals, healthcare and biotech sectors in Africa & the World

HealthCareAfro
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 2, 2023

#HCMEAMagazine #Issue4
As we mark World Cancer Day this Saturday, 4th February, we highlight the cancer burden and strategies being explored by experts, particularly in Africa, to contain the disease in this article.

Have a read on the link below;

https://t.co/MOvJjCYz30

Reply on Twitter 1621057821566709760 Retweet on Twitter 1621057821566709760 Like on Twitter 1621057821566709760 1 Twitter 1621057821566709760
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 2, 2023

#NationalCancerSummit2023
The HealthCare Middle East & Africa Magazine team is present at the National Cancer Summit @NCIKenya that is happening at Safari Park Hotel, Nairobi.

Visit our booth to get more insights about our magazine.

https://t.co/G8kVljPfqY

4

Reply on Twitter 1621049414629625857 Retweet on Twitter 1621049414629625857 1 Like on Twitter 1621049414629625857 Twitter 1621049414629625857
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 2, 2023

Innovate Life Sciences Lab has launched its new genomics testing laboratory based at @DxbSciencePark that will use #ArtificialIntelligence to advance precision medicine

https://t.co/XaOEUInRXz

#LifeSciences #Genomics #testing #UAE #Dubai #healthcare #lab #clinicalresearch

Reply on Twitter 1621033276528893952 Retweet on Twitter 1621033276528893952 Like on Twitter 1621033276528893952 Twitter 1621033276528893952
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 2, 2023

UK supports Malawi with US$0.59m for cholera emergency response

https://t.co/b2jaLhxAl3

#digitalhealth #healthtech #innovation #hospitals #healthscience #technology #Covid19 #Vaccines #pharmaceuticals #manufacturing #healthcare #regulatory #medical

Reply on Twitter 1621027573915422721 Retweet on Twitter 1621027573915422721 2 Like on Twitter 1621027573915422721 1 Twitter 1621027573915422721
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 2, 2023

Ghana successfully eliminates Human African Trypanosomiasis

https://t.co/UWijC0yg8E

#digitalhealth #healthtech #innovation #hospitals #healthscience #technology #Covid19 #Vaccines #pharmaceuticals #manufacturing #healthcare #regulatory #medical

Reply on Twitter 1621027388397350913 Retweet on Twitter 1621027388397350913 1 Like on Twitter 1621027388397350913 Twitter 1621027388397350913
Load More...

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa

Food Business Africa

Food Safety Africa

Milling & Baking Africa

Sustainable Packaging Africa

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.